Tumor suppressive microRNA-133a regulates novel targets: Moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma

Biochemical and Biophysical Research Communications

Volumn 418, Issue 2, 2012, Pages 378-383

  Kinoshita, Takashi ^a   Nohata, Nijiro ^a   Fuse, Miki ^a   Hanazawa, Toyoyuki ^a   Kikkawa, Naoko ^a   Fujimura, Lisa ^b   Watanabe Takano, Haruko ^b   Yamada, Yasutoshi ^c   Yoshino, Hirofumi ^c   Enokida, Hideki ^c   Nakagawa, Masayuki ^c   Okamoto, Yoshitaka ^a   Seki, Naohiko ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Head and neck squamous cell carcinoma; MicroRNA; MicroRNA 133a; Moesin; Tumor suppressor

Indexed keywords

EZRIN; MICRORNA; MICRORNA 133A; MOESIN; RADIXIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; MALE; MOLECULARLY TARGETED THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MICROFILAMENT PROTEINS; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS;

EID: 84856630507     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.01.030     Document Type: Article

References (37)

1. Jemal A., Siegel R., Xu J., et al. Cancer statistics, 2010. CA Cancer J. Clin. 2010, 60:277-300.
2. Leemans C.R., Braakhuis B.J., Brakenhoff R.H. The molecular biology of head and neck cancer. Nat. Rev. Cancer 2011, 11:9-22.
3. Mattick J.S. RNA regulation: a new genetics?. Nat. Rev. Genet. 2004, 5:316-323.
4. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat. Rev. Genet. 2008, 9:102-114.
5. Nelson K.M., Weiss G.J. MicroRNAs and cancer: past, present, and potential future. Mol. Cancer Ther. 2008, 7:3655-3660.
6. Esquela-Kerscher A., Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6:259-269.
7. Kano M., Seki N., Kikkawa N., et al. MiR-145, miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int. J. Cancer 2010, 127:2804-2814.
8. S. Kojima, T. Chiyomaru, K. Kawakami, et al., Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer, Br. J. Cancer, in press.
9. Y. Moriya, N. Nohata, T. Kinoshita, et al., Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma, J. Hum. Genet., in press.
10. Nohata N., Hanazawa T., Kikkawa N., et al. Caveolin-1 mediates tumor cell migration and invasion and its regulation by miR-133a in head and neck squamous cell carcinoma. Int. J. Oncol. 2011, 38:209-217.
11. Nohata N., Hanazawa T., Kikkawa N., et al. Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma. Br. J. Cancer 2011, 105:833-841.
12. Nohata N., Hanazawa T., Kikkawa N., et al. Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma. Int. J. Oncol. 2011, 39:1099-1107.
13. Yoshino H., Chiyomaru T., Enokida H., et al. The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br. J. Cancer 2011, 104:808-818.
14. Chiyomaru T., Enokida H., Tatarano S., et al. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br. J. Cancer 2010, 102:883-891.
15. Arpin M., Chirivino D., Naba A., et al. Emerging role for ERM proteins in cell adhesion and migration. Cell Adhes. Migr. 2011, 5:199-206.
16. Yu H., Zhang Y., Ye L., et al. The FERM family proteins in cancer invasion and metastasis. Front. Biosci. 2011, 16:1536-1550.
17. He M., Cheng Y., Li W., et al. Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade. BMC Cancer 2010, 10:170.
18. Ou-Yang M., Liu H.R., Zhang Y., et al. ERM stable knockdown by siRNA reduced in vitro migration and invasion of human SGC-7901 cells. Biochimie 2011, 93:954-961.
19. Ichikawa T., Masumoto J., Kaneko M., et al. Moesin and CD44 expression in cutaneous melanocytic tumours. Br. J. Dermatol. 1998, 138:763-768.
20. Abiatari I., Esposito I., Oliveira T.D., et al. Moesin-dependent cytoskeleton remodelling is associated with an anaplastic phenotype of pancreatic cancer. J. Cell Mol. Med. 2010, 14:1166-1179.
21. Ichimi T., Enokida H., Okuno Y., et al. Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int. J. Cancer 2009, 125:345-352.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
23. Kikkawa N., Hanazawa T., Fujimura L., et al. MiR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC). Br. J. Cancer 2010, 103:877-884.
24. Mutallip M., Nohata N., Hanazawa T., et al. Glutathione S-transferase P1 (GSTP1) suppresses cell apoptosis and its regulation by miR-133alpha in head and neck squamous cell carcinoma (HNSCC). Int. J. Mol. Med. 2011, 27:345-352.
25. Wong T.S., Liu X.B., Chung-Wai Ho A., et al. Identification of pyruvate kinase type M2 as potential oncoprotein in squamous cell carcinoma of tongue through microRNA profiling. Int. J. Cancer 2008, 123:251-257.
26. Kang Y.K., Hong S.W., Lee H., et al. Prognostic implications of ezrin expression in human hepatocellular carcinoma. Mol. Carcinog. 2010, 49:798-804.
27. Elliott B.E., Meens J.A., SenGupta S.K., et al. The membrane cytoskeletal crosslinker ezrin is required for metastasis of breast carcinoma cells. Breast Cancer Res. 2005, 7:R365-R373.
28. Deng X., Tannehill-Gregg S.H., Nadella M.V., et al. Parathyroid hormone-related protein and ezrin are up-regulated in human lung cancer bone metastases. Clin. Exp. Metastasis 2007, 24:107-119.
29. Lyng H., Brovig R.S., Svendsrud D.H., et al. Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer. BMC Genomics 2006, 7:268.
30. Carmeci C., Thompson D.A., Kuang W.W., et al. Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype. Surgery 1998, 124:211-217.
31. Cui Y., Wu J., Zong M., et al. Proteomic profiling in pancreatic cancer with and without lymph node metastasis. Int. J. Cancer 2009, 124:1614-1621.
32. Estecha A., Sanchez-Martin L., Puig-Kroger A., et al. Moesin orchestrates cortical polarity of melanoma tumour cells to initiate 3D invasion. J. Cell Sci. 2009, 122:3492-3501.
33. Belbin T.J., Singh B., Smith R.V., et al. Molecular profiling of tumor progression in head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 2005, 131:10-18.
34. Howe E.N., Cochrane D.R., Richer J.K. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast Cancer Res. 2011, 13:R45.
35. Park S.M., Gaur A.B., Lengyel E., et al. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008, 22:894-907.
36. Jurmeister S., Baumann M., Balwierz A. MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F, Mol. Cell Biol. 2012, 32:633-651.
37. T. Chiyomaru, H. Enokida, K. Kawakami, et al., Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer, Urol. Oncol., in press.